These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35119495)

  • 21. Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial.
    Perissinotto MC; DʼAncona CA; Lucio A; Campos RM; Abreu A
    J Wound Ostomy Continence Nurs; 2015; 42(1):94-9. PubMed ID: 25549314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
    Stewart F; Gameiro LF; El Dib R; Gameiro MO; Kapoor A; Amaro JL
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010098. PubMed ID: 27935011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    Tu H; Li N; Liu W; Fan Z; Kong D
    PLoS One; 2022; 17(7):e0269371. PubMed ID: 35901036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
    Peters KM; Carrico DJ; Perez-Marrero RA; Khan AU; Wooldridge LS; Davis GL; Macdiarmid SA
    J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial.
    Wagner L; Alonso S; Le Normand L; Faix A; Kabani S; Castelli C; Gamé X; Cornu JN; Bey E
    Neurourol Urodyn; 2020 Nov; 39(8):2230-2237. PubMed ID: 32835443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C; Morosetti C; Berouz A; Giannubilo W; Ferrara V
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM; Eltabey NA; Wadie BS
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson's Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson's disease using a self-contained wearable device.
    Smith MD; Tenison E; Drake MJ; Ben-Shlomo Y; Henderson EJ
    Trials; 2022 Oct; 23(1):912. PubMed ID: 36307874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review.
    Sayner AM; Rogers F; Tran J; Jovanovic E; Henningham L; Nahon I
    Neuromodulation; 2022 Dec; 25(8):1086-1096. PubMed ID: 35688702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis.
    Lo CW; Wu MY; Yang SS; Jaw FS; Chang SJ
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
    MacDiarmid S; Staskin DR; Lucente V; Kaaki B; English S; Gilling P; Meffan P; Clark M; Sand PK; Sen SK; Rovner E
    J Urol; 2019 May; 201(5):967-972. PubMed ID: 31009968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
    Zinkgraf K; Quinn AO; Ketterhagen D; Kreuziger B; Stevenson K
    Urol Nurs; 2009; 29(1):30-4. PubMed ID: 19331273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonantimuscarinic treatment for overactive bladder: a systematic review.
    Olivera CK; Meriwether K; El-Nashar S; Grimes CL; Chen CC; Orejuela F; Antosh D; Gleason J; Kim-Fine S; Wheeler T; McFadden B; Balk EM; Murphy M;
    Am J Obstet Gynecol; 2016 Jul; 215(1):34-57. PubMed ID: 26851599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study.
    Cava R; Orlin Y
    Int Urol Nephrol; 2022 Aug; 54(8):1825-1835. PubMed ID: 35622269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
    Gilling P; Meffan P; Kaaki B; MacDiarmid S; Lucente V; Clark M; Sen SK; English S; Sand PK
    Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.